Add-On tolterodine extended release improves overactive bladder symptoms in men receiving alpha-blocker therapy

被引：0
作者：
Chapple, C. [1 ]
Abrams, P. [2 ]
Herschorn, S. [3 ]
Sun, F. [4 ]
Brodsky, M. [5 ]
Guan, Z. [5 ]
机构：
[1] Royal Hallamshire Hosp, Dept Urol, Sheffield S10 2JF, S Yorkshire, England
[2] Bristol Urol Inst, Dept Urol, Bristol, Avon, England
[3] Univ Toronto, Dept Urol, Toronto, ON, Canada
[4] Pfizer Inc, Dept Stat, New York, NY USA
[5] Pfizer Inc, Dept Med Urol, New York, NY USA
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2008年 / 7卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
671
引用
收藏
页码：239 / 239
页数：1
相关论文
共 50 条
[1]   Add-on tolterodine extended release improves overactive bladder symptoms in men receiving α-blocker therapy [J].
Herschorn, Sender ;
Abrams, Paul ;
Chapple, Christopher R. ;
Sun, Franklin ;
Brodsky, Marina ;
Guan, Zhonghong .
JOURNAL OF UROLOGY, 2008, 179 (04) :443-443
[2]   Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia [J].
Kaplan, Steven A. ;
Roehrborn, Claus G. ;
Dmochowski, Roger ;
Rovner, Eric S. ;
Wang, Joseph T. ;
Guan, Zhonghong .
UROLOGY, 2006, 68 (02) :328-332
[3]   Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving a-blocker treatment for lower urinary tract symptoms [J].
Kaplan, Steven A. ;
Roehrborn, Claus G. ;
Gong, Jason ;
Sun, Franklin ;
Guan, Zhonghong .
BJU INTERNATIONAL, 2012, 109 (12) :1831-1840
[4]   Effects of tolterodine extended release on patient perception of bladder condition and overactive bladder symptoms [J].
Herschorn, Sender ;
Heesakkers, John ;
Castro-Diaz, David ;
Wang, Joseph T. ;
Brodsky, Marina ;
Guan, Zhonghong .
CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (12) :3513-3521
[5]   Meta-Analysis of the Efficacy and Safety of Imidafenacin for Overactive Bladder Induced by Benign Prostatic Hyperplasia in Men Receiving Alpha-Blocker Therapy [J].
Cai, Tong ;
Wang, Ning ;
Liang, Liye ;
Zhou, Zhongbao ;
Zhang, Yong ;
Cui, Yuanshan .
INTERNATIONAL NEUROUROLOGY JOURNAL, 2020, 24 (04) :365-374
[6]   Efficacy and safety of tolterodine extended-release in men with overactive bladder symptoms treated with an α-blocker: effect of baseline prostate-specific antigen concentration [J].
Chapple, Christopher R. ;
Herschorn, Sender ;
Abrams, Paul ;
Wang, Joseph T. ;
Brodsky, Marina ;
Guan, Zhonghong .
BJU INTERNATIONAL, 2010, 106 (09) :1332-1338
[7]   TOLTERODINE EXTENDED RELEASE IMPROVES OVERACTIVE BLADDER SYMPTOMS IN MEN TREATED WITH α-BLOCKERS IRRESPECTIVE OF BASELINE SERUM PROSTATE-SPECIFIC ANTIGEN LEVEL [J].
Chapple, C. R. ;
Herschorn, S. ;
Abrams, P. ;
Wang, J. T. ;
Brodsky, M. ;
Guan, Z. ;
Al-Gamal, S. A. ;
Ragab, M. ;
Abo, Farha O. M. ;
Taha, M. R. .
EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) :166-166
[8]   Effects of tolterodine extended release and/or tamsulosin on bladder diary variables in men with lower urinary tract symptoms including overactive bladder [J].
Kaplan, Steven A. ;
Rovner, Eric S. ;
Sussman, David O. ;
Kreder, Karl ;
Carlsson, Martin ;
Bavendam, Tamara ;
Guan, Zhonghong .
JOURNAL OF UROLOGY, 2007, 177 (04) :512-513
[9]   Tolterodine Treatment Improves Storage Symptoms Suggestive of Overactive Bladder in Men Treated With α-Blockers [J].
Chapple, Christopher ;
Herschorn, Sender ;
Abrams, Paul ;
Sun, Franklin ;
Brodsky, Marina ;
Guan, Zhonghong .
EUROPEAN UROLOGY, 2009, 56 (03) :534-541
[10]   Efficacy of tolterodine extended release for overactive bladder symptoms in sexually active postmenopausal women [J].
Bachmann, Gloria ;
Wang, Joseph T. ;
Morrow, Jon D. ;
Bavendam, Tamara .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (06) :1082-1082
12345